Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-08

Clinical Trial Update: Study of Pregnancy Outcomes in Women Exposed to Rimegepant During Pregnancy

View source ↗

Summary

Clinical trial update on pregnancy outcomes in women exposed to rimegepant during pregnancy; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rimegepant (rimegepant)

Snippet

Sponsor: Pfizer | Conditions: Migraine | Status: ACTIVE_NOT_RECRUITING